AOTI (LSE:AOTI) Debt-to-EBITDA : (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:AOTI AOTI Inc LSE:AOTI
13 GF Score
Price £1.30
! 11 Warning Signs
View Full Analysis

What is AOTI Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

AOTI's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was £0.31 Mil. AOTI's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2025 was £15.44 Mil. AOTI's annualized EBITDA for the quarter that ended in Dec. 2025 was £6.68 Mil. AOTI's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2025 was 2.36.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for AOTI's Debt-to-EBITDA or its related term are showing as below:

LSE:AOTI' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -2.89   Med: 2.81   Max: 26.06
Current: 2.82

During the past 5 years, the highest Debt-to-EBITDA Ratio of AOTI was 26.06. The lowest was -2.89. And the median was 2.81.

LSE:AOTI's Debt-to-EBITDA is ranked worse than
69.21% of 471 companies
in the Medical Devices & Instruments industry
Industry Median: 1.64 vs LSE:AOTI: 2.82

AOTI  (LSE:AOTI) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

AOTI Debt-to-EBITDA Related Terms

AOTI Debt-to-EBITDA Historical Data

* Premium members only.

The historical data trend for AOTI's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AOTI Debt-to-EBITDA Chart

AOTI Annual Data
Trend Sep21 Sep22 Dec23 Dec24 Dec25
Debt-to-EBITDA
- - - - -

AOTI Semi-Annual Data
Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Debt-to-EBITDA Get a 7-Day Free Trial - - - - -

LSE:AOTI vs ABT, SYK, MDT: Debt-to-EBITDA Comparison

For the Medical Devices subindustry, AOTI's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

AOTI Debt-to-EBITDA vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, AOTI's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where AOTI's Debt-to-EBITDA falls into.


LSE:AOTI
13GF Score
AOTI Inc LSE:AOTI
Debt-to-EBITDA is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AOTI Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

AOTI's Debt-to-EBITDA for the fiscal year that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.30556484889038 + 15.444779004498) / 5.7227830145392
=2.75

AOTI's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2025 is calculated as

Debt-to-EBITDA=Total Debt / EBITDA
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / EBITDA
=(0.30556484889038 + 15.444779004498) / 6.6790563276632
=2.36

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2025) EBITDA data.

AOTI Business Description

Address 3512 Seagate Way, Suite 100, Oceanside, CA, USA, 92056
AOTI Inc is the design, manufacture and provision of topical oxygen therapy products and services for healthcare providers and patients with chronic wounds. These products and services enable patients to heal faster and more durably and healthcare providers to reduce the overall cost of care. The specific purposes of the Company are to patent, manufacture, rent, and sell medical devices to help resolve severe acute and chronic wounds for customers globally. The Company operates in one reportable segment, which comprises the development and sale of Creative medical devices for therapeutic care. The company's solutions includes Multi-Modality Oxygen Therapy, Extremity Chamber, Multi-Patch, Negative Pressure Wound Therapy.
13GF Score

Get the complete analysis for LSE:AOTI

Debt-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£1.30
Price